Showing results (31-40 of 141) with videos related to
Sort By:
Pageof 15
Advances in Radiation Oncology|January 12, 2023
Radiation Therapy Modulates Tumor Physical Characteristics to Reduce Intratumoral Pressure and Enhance Intratumoral Drug Delivery and RetentionHampartsoum B Barsoumian, Rahul A Sheth, Rishab Ramapriyan, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 30, 2013
Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinomaCaitlin C Murphy, Arlene M Correa, Jaffer A Ajani, et al.International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomesChad Tang, Zhongxing Liao, Daniel Gomez, et al.International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer OligometastasesVivek Verma, Nikhil Yegya-Raman, Tanja Sprave, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2017
Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on SurvivalMiho Kono, Pamela K Allen, Steven H Lin, et al.International Journal of Radiation Oncology, Biology, Physics|September 15, 2012
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderlyShervin M Shirvani, Jing Jiang, Joe Y Chang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2014
Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indicationsQiaoqiao Li, Cameron W Swanick, Pamela K Allen, et al.Frontiers in Immunology|November 10, 2022
Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistanceShonik Ganjoo, Nahum Puebla-Osorio, Selene Nanez, et al.Cancer|June 27, 2013
Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancerJoe Y Chang, Yung-Hsien Liu, Zhengfei Zhu, et al.Cancer Immunology, Immunotherapy : CII|June 8, 2023
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant modelHampartsoum B Barsoumian, Kewen He, Ethan Hsu, et al.Pageof 15